| Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
|---|
| 01/20/2004 | US6680296 Compositions comprising bouganin and a cell binding ligand are particularly useful to kill cells of a target population |
| 01/20/2004 | US6680074 Potent antiviral, antibacterial or antimycotic activity |
| 01/20/2004 | US6680072 Producing small, rapidly disintegrating masked tablets; st. john's wort |
| 01/20/2004 | US6680067 Analgesic in admixture with injectable oil; nalbuphine free base or a pharmaceutically acceptable salt |
| 01/20/2004 | US6680047 Diagnostic/therapeutic agents |
| 01/20/2004 | US6680046 Preventing catheter clogging using uniform, high impact strength particles |
| 01/20/2004 | CA2383742C Silver-based antimicrobial compositions |
| 01/20/2004 | CA2208322C Directly compressible high load acetaminophen formulations |
| 01/20/2004 | CA2157323C Gepirone dosage form |
| 01/15/2004 | WO2004005470A2 Antibodies to non-shed muc1 and muc16, and uses thereof |
| 01/15/2004 | WO2004005423A1 Allergen inactivator |
| 01/15/2004 | WO2004005326A2 Tubulysin conjugates |
| 01/15/2004 | WO2004005313A2 Hybrid molecules of macrolides with steroid/non-steroid anti-inflammatory, antineoplastic and antiviral active molecules |
| 01/15/2004 | WO2004005237A1 Method of preparing hydroxytyrosol esters, esters thus obtained and use of same |
| 01/15/2004 | WO2004005227A1 Crystallization of polyol compositions, crystalline polyol composition product and use thereof |
| 01/15/2004 | WO2004004794A1 Resin compatible with body fluid and living tissue |
| 01/15/2004 | WO2004004786A1 Scanning suspension comprising a particle with a diameter of at least 1 micrometer |
| 01/15/2004 | WO2004004781A1 LIQUID FORMULATIONS WITH HIGH CONCENTRATION OF HUMAN GROWTH HORMONE (hgh) COMPRISING 1,2-PROLPYLENE GLYCOL |
| 01/15/2004 | WO2004004780A1 Liquid formulations with high concentration of human growth hormone (hgh) comprising phenol |
| 01/15/2004 | WO2004004779A1 Liquid formulations with a high concentration of human growth hormone (hgh) comprising glycine |
| 01/15/2004 | WO2004004775A1 Novel drug compositions based on novel anticholinergics and inhibitors of egfr-kinase |
| 01/15/2004 | WO2004004769A1 Conjugates of photosensitizers and oligonucleotides for selective photochemiotherapy |
| 01/15/2004 | WO2004004758A1 Method to enhance an immune response of nucleic acid vaccination |
| 01/15/2004 | WO2004004757A1 Treatment for eye disorder |
| 01/15/2004 | WO2004004745A1 Carbon dioxide external preparation and material for formation of carbon dioxide external preparation |
| 01/15/2004 | WO2004004744A1 Compositions of hyaluronic acid and methods of use |
| 01/15/2004 | WO2004004739A1 Ciclesonide-containing sterile aqueous suspension |
| 01/15/2004 | WO2004004725A2 Pharmaceutical compositions of anticholinergics and p38 kinase inhibitors in the treatment of respiratory diseases |
| 01/15/2004 | WO2004004724A1 Novel pharmaceutical compositions comprising novel anticholinergic agents and nk1-receptor antagonists |
| 01/15/2004 | WO2004004713A1 Fredericamycin derivatives as medicaments for treating tumours |
| 01/15/2004 | WO2004004708A1 A pharmaceutical composition useful for treating chronic myeloid leukemia |
| 01/15/2004 | WO2004004705A2 Pharmaceutical formulations for preparing drink products |
| 01/15/2004 | WO2004004704A1 Novel pharmaceutical compositions comprising novel anticholinergic agents and pde-iv inhibitors |
| 01/15/2004 | WO2004004696A1 Controlled release composition |
| 01/15/2004 | WO2004004690A1 Liquid dosage forms of proton pump inhibitors |
| 01/15/2004 | WO2004004689A1 Compositions and methods for amelioration of human female sexual dysfunction |
| 01/15/2004 | WO2004004688A1 Injectable system for controlled drug delivery |
| 01/15/2004 | WO2004004687A2 Liposomal vaccine |
| 01/15/2004 | WO2004004686A2 Cartilage enhancing food supplements and methods of preparing the same |
| 01/15/2004 | WO2004004683A1 Solid dispersions comprising two different polymer matrixes |
| 01/15/2004 | WO2004004667A2 Method of immunotherapy |
| 01/15/2004 | WO2004004663A2 Compositions and methods for ligament growth and repair |
| 01/15/2004 | WO2004004639A2 A novel stable formulation |
| 01/15/2004 | WO2004004599A2 Epa and dha enriched omega-3 supplement for the treatment of dry eye, meibomianitis and xerostomia |
| 01/15/2004 | WO2004004483A1 Vitamin-containing system for stabilising the immune response of animals |
| 01/15/2004 | WO2004004456A1 Antimicrobial concentrates |
| 01/15/2004 | WO2003092608A3 Methionine aminopeptidase-2 inhibitors and methods of use thereof |
| 01/15/2004 | WO2003090722A3 Microparticle pharmaceutical compositions for intratumoral delivery |
| 01/15/2004 | WO2003088920A8 Low profile combination device for gastrostomy or jejunostomy applications having anti-granuloma formation characteristics |
| 01/15/2004 | WO2003086272A3 Ultrapure transferrin for pharmaceutical compositions |
| 01/15/2004 | WO2003085019A8 Cross-linked polyurethanes consisting of polytetrahydrofuran |
| 01/15/2004 | WO2003082191A3 Substituted 2,3-diphenyl pyridines |
| 01/15/2004 | WO2003077943A3 Method for the production of a pharmaceutical preparation by adsorption in a poorly soluble aluminum compound |
| 01/15/2004 | WO2003072021A3 Oral pediatric trimethobenzamide formulations and methods |
| 01/15/2004 | WO2003070905A3 Electroporation methods for introducing bioactive agents into cells |
| 01/15/2004 | WO2003070895A3 RNA INTERFERENCE MEDIATED TREATMENT OF ALZHEIMER'S DISEASE USING SHORT INTERFERING NUCLEIC ACID (siNA) |
| 01/15/2004 | WO2003068936A3 Inhibition of lung metastases by aerosol delivery of p53 gene and anti-cancer compounds |
| 01/15/2004 | WO2003066073A3 Compositions containing oat straw and willowherb extract |
| 01/15/2004 | WO2003059274A3 Vitamin formulation for cardiovascular health |
| 01/15/2004 | WO2003057170A8 Oral insulin therapy |
| 01/15/2004 | WO2003057148A3 Use of biomolecular targets in the treatment and visualization of tumors |
| 01/15/2004 | WO2003053401A3 Formulation and dosage form for increasing oral bioavailability of hydrophilic macromolecules |
| 01/15/2004 | WO2003052117A3 Methods and products related to non-viral transfection |
| 01/15/2004 | WO2003051332A8 Ophthalmic compositions comprising two different polyanionic components for lubricating eyes and methods for making and using same |
| 01/15/2004 | WO2003050271A3 In vitro production of dendritic cells from cd14+ monocytes |
| 01/15/2004 | WO2003045307A3 Pharmaceutical formulations comprising indolinone derivatives |
| 01/15/2004 | WO2003040169A3 Human monoclonal antibodies to dendritic cells |
| 01/15/2004 | WO2003004620A3 Polynucleotides encoding antigenic hiv type c polypeptides, polypeptides and uses thereof |
| 01/15/2004 | WO2002072010A3 Taxane prodrugs |
| 01/15/2004 | WO2002056833A3 Preparation of a therapeutic composition |
| 01/15/2004 | US20040010811 Mixture comprising modulator for cancer activity; anticarcinogenic agents; tumor diagnosis; immunotherapy |
| 01/15/2004 | US20040010290 Method and device for treating cancer with electrical therapy in conjunction with chemotherapeutic agents and radiation therapy |
| 01/15/2004 | US20040010224 Drug delivery by in situ formation of an implant or particles in the body after exposure of a carrier phase to physiological conditions or environment; kit containing separately solvent for the carrier (polymer); sustained release |
| 01/15/2004 | US20040010215 Silver-containing compositions, devices and methods for making |
| 01/15/2004 | US20040010135 Comprises nucleotide sequences coding polypeptide for preventing and viral infection; viricides |
| 01/15/2004 | US20040010134 Albumin fusion proteins |
| 01/15/2004 | US20040010060 Multilayer block polymer |
| 01/15/2004 | US20040010054 Pressure sensitive adhesives; acrylated resins; transdermal administering |
| 01/15/2004 | US20040010000 Methods and dosage forms for controlled delivery of oxycodone |
| 01/15/2004 | US20040009962 Combined estrogen blockade of the breast with exemestane and raloxifene |
| 01/15/2004 | US20040009956 Treating type II diabetes and obesity |
| 01/15/2004 | US20040009941 Microspheres and adjuvants for DNA vaccine delivery |
| 01/15/2004 | US20040009918 Containing a buffer and having a moisture content of 3% or less; the pH of said composition is 4 to 7 when dissolved in water. |
| 01/15/2004 | US20040009914 Novel curcuminoid-factor VIIa constructs as suppressors of tumor growth and angiogenesis |
| 01/15/2004 | US20040009910 Compositions and methods for treating infections using analogues of indolicidin |
| 01/15/2004 | US20040009900 Soluble molecular complex comprising an expressible gene encoding the secretory protein complexed with a carrier of a cell-specific binding agent and a gene-binding agent which releases the gene under intracellular conditions |
| 01/15/2004 | US20040009897 Stabilized synthetic immunogen delivery system |
| 01/15/2004 | US20040009553 Comprises nucleotide sequences coding cardiolipin for diagnosis and treatment of lung, heart and respiratory disorders |
| 01/15/2004 | US20040009248 Method for improving the cell protection |
| 01/15/2004 | US20040009233 Shark meat extract |
| 01/15/2004 | US20040009232 Dispersion of a liposoluble substance in water in the presence of a surfactant, adding a water soluble polyhydroxylated solid excipient such as mannitol, and granulating; drug delivery of megestrol acetate; excellent water dispersibility |
| 01/15/2004 | US20040009231 hGH (human growth hormone) formulations for pulmonary administration |
| 01/15/2004 | US20040009229 Stabilized nanoparticle formulations of camptotheca derivatives |
| 01/15/2004 | US20040009228 Bioabsorbable drug delivery system for local treatment and prevention of infections |
| 01/15/2004 | US20040009226 Injectable system for controlled drug delivery |
| 01/15/2004 | US20040009223 Matrix-forming agent, a bioadhesive, a buffer, and water; for use in the vagina; forms a semisolid matrix on contact with semen and causes hardening of cervical mucus; for STD (sexually transmitted disease) prevention and contraception |
| 01/15/2004 | US20040009222 Processes for forming a drug delivery device |
| 01/15/2004 | US20040009221 Particularly ketorolac; pain treatment; core, a drug layer (which comprises the drug, a binder, and a disintegrant), a protecting layer, and an enteric coating |
| 01/15/2004 | US20040009217 Therapeutic liposome composition and method |
| 01/15/2004 | US20040009216 Administering liposomes comprising phospholipids and an aqueous layer, said liposomes having specified average diameter; treating various cardiovascular disorders, reducing cholesterol |